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The authors are retracting this article [1]. Careful re-
examination of the transgenic mice used in this study
has indicated that they contain a transgenic sequence
containing a 90CGG repeat, associated with fragile
X-associated tremor/ataxia syndrome (FXTAS). Apparently,
a mixture of two constructs containing the G4C2 repeat
and the CGG repeat sequence was injected in oocytes to
generate transgenic mice. The presence of the CGG
repeat can explain the neuropathology described in the
mice used for this study. We are therefore unable to
present this transgenic mouse as model for C9orf72
related amyotrophic lateral sclerosis (ALS) and frontotem-
poral dementia (FTD).
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